Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 274-278, Vol. 7, No. 2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Transmission of Human T-Cell Lymphotropic Virus
Type 1 Tax to Rabbits by tax-Only-Positive Human
Cells
Dorothea
Zucker-Franklin,1,*
Bette A.
Pancake,1
Parviz
Lalezari,2 and
Manoochehr
Khorshidi2
New York University School of Medicine, New
York, New York,1 and Bergen
Community Regional Blood Center, Paramus, New
Jersey2
Received 27 October 1999/Returned for modification 6 December
1999/Accepted 20 December 1999
 |
ABSTRACT |
The human T-cell lymphrotropic virus type 1 (HTLV-1) is causally
related to adult T-cell leukemia and lymphoma and the neurodegenerative diseases tropical spastic paraparesis and HTLV-1-associated myelopathy. In the United States the prevalence of infection has been estimated to
range from 0.016 to 0.1% on the basis of serologic tests for antibodies to the viral structural proteins. Blood from donors positive
for antibodies to HTLV-1 or HTLV-2 is not used for transfusion. However, patients with the cutaneous T-cell lymphoma mycosis fungoides (MF) are HTLV-1 and -2 seronegative yet harbor proviral sequences identical to those that encode the HTLV-1 transactivating and transforming gene product p40tax in their peripheral blood
mononuclear cells (PBMCs), and they usually have antibodies to
p40tax. Moreover, a study of 250 randomly
selected blood donors revealed that approximately 8% of these
seronegative individuals also had HTLV-1 tax sequences and
antibodies to p40tax, while they lacked
sequences and antibodies related to gag, pol, or env. Thus, it seemed important to determine whether the
"tax-only" state can be transmitted by transfusion. To
this end, PBMCs from HTLV-1 and -2 seronegative
tax-only-positive MF patients or from healthy
tax-only-positive blood donors were injected into adult rabbits, an established animal model for HTLV-1 infection. The PBMCs of
all injected rabbits became tax sequence positive. These observations suggest that HTLV-1 tax can be transmitted by
tax-only-positive mononuclear cells.
 |
INTRODUCTION |
The human T-cell lymphotropic virus
(HTLV) type 1 (HTLV-1) is causally associated with adult T-cell
leukemia and lymphoma (27) as well as with the nonneoplastic
conditions tropical spastic paraparesis (5) and
HTLV-associated myelopathy (22). The vast majority of
patients with these diseases as well as healthy carriers of HTLV-1 have
antibodies to the structural proteins of this virus. Because infection
has been shown to be transmitted by transfusion (18, 21),
all blood collected for this purpose has been screened for antibodies
to this virus since 1988 (2). However, subsequent studies
with patients with the cutaneous T-cell lymphoma mycosis fungoides (MF)
revealed that the majority carry the proviral tax sequence
of HTLV-1 in their peripheral blood mononuclear cells (PBMCs) and
skin-infiltrating lymphocytes, while they have no antibodies to the
structural proteins of the virus (14, 24). This raised the
question of whether the "tax-only"-positive state may
also pertain to some healthy, serologically negative blood donors.
Indeed, on the basis of serologic tests for 250 randomly selected
donors who presented at the New York University Medical Center blood
bank, 8.6% proved to harbor proviral HTLV-1 tax in their
PBMCs and also had antibodies to p40tax, the
protein encoded by this sequence (36, 39). Therefore, a
study to determine whether the tax-only state could be
transmitted by transfusion of tax-positive cells seemed to
be indicated. It should be recalled here that HTLV-1 tax
functions in the transcriptional transactivation of the HTLV-1 long
terminal repeat and the transactivation of numerous cellular genes,
particularly those involved in inflammation and cell proliferation,
such as interleukin-1 (IL-1), IL-2, the
subunit of the IL-2
receptor, IL-6, granulocyte-macrophage colony-stimulating factor, and
tumor necrosis factor alpha, the adhesion molecules ICAM-I and LFA-I in
addition to several oncogenes, including jun, fos, rel, myc, and ets
(1, 6, 35). In vitro, tax has been shown to be
taken up by PBMCs, to stimulate proliferation of cultured cells, and to
dysregulate immunoglobulin production by B cells (19, 26).
Last, but not least, mice made transgenic for HTLV-1 tax
develop a variety of malignant neoplasms as well as autoimmune conditions, such as rheumatoid arthritis and Sjögren's syndrome (7, 10, 26). Rabbits were used as recipients of
tax-only-positive cells, since this species has proven to be
a useful animal model for HTLV-1 infection (3, 17). Cells
obtained from patients with MF and/or tax-only-positive
healthy blood donors were injected intravenously into this animal
species. Positive control animals received cells of the C91PL cell
line, a tissue culture cell line infected with prototypic HTLV-1
(28). The PBMCs of all animals became tax
sequence positive. As anticipated, the PBMCs of rabbits injected
with virus-infected C91PL cells also had gag and
env sequences. Neither the animals injected with
HTLV-1-infected cells containing proviral sequences spanning the entire
viral genome nor the ones injected with cells containing only
tax sequences developed antibodies to
p40tax, an antibody whose development is known
to be late (11). The observations suggest that the
tax-only state can be transmitted by cells that harbor only
this incomplete, theoretically replication-defective viral sequence,
which may, however, have pathophysiologic implications.
 |
MATERIALS AND METHODS |
Origins of tax-only-positive donor cells, cell
preparation, and animals.
Peripheral blood was obtained from
patients with MF and from healthy blood donors, whose cells were HTLV-1
tax-only positive and who had antibodies to
p40tax while being serologically negative for
antibodies to HTLV-1 and -2. PBMCs from the
tax-only-positive donors had previously been shown by
PCR-Southern analysis to harbor tax but not
gag-1, gag-2, gag-1 and -2 pol-1, pol-2, or env-1 sequences (24,
25, 39, 40). Donor cells for this study were prepared by
Ficoll-Hypaque gradient centrifugation, as routinely carried out in
this laboratory (38), after which they were suspended at a
concentration of 108 per ml of physiologic saline. The
cells were used within 1 to 3 days of collection.
Outbred 3-kg female New Zealand White rabbits were purchased from
Charles River Laboratories (Wilmington, Mass.). They were bled from the
central ear arteries, and injections were given in marginal ear veins.
On days when animals were both bled for testing of blood and injected,
bleeding always preceded injection. Control specimens were obtained
from all animals before the first injection. Two rabbits (rabbits A and
B) received injections of 108 HTLV-1-infected C91PL cells
on day 0 and at 3 and 5 months (Table 1).
Rabbits C, D, E, F, G, H, and I were injected with 108
PBMCs obtained from patients with MF or healthy blood donors at the
following times: rabbit C, on day 0 and at 3, 4, 5, and 7 months;
rabbit D, on day 0 and at 3, 4, 5, 7, and 8 months; rabbit E, on day 0 and at 3, 4, 7, and 9 months; rabbit F, on day 0 and at 3, 4, 5, and 7 months; rabbit G, on day 0 and at 3, 4, 5, 7, 8, and 9 months; rabbit
H, on day 0 and at 3, 4, and 7 months; and rabbit I, on day 0 and at 9 months. The injection schedule was, to a large extent, contingent on
the availability of tax-only-positive patients and/or blood
donors.
Detection of proviral DNA sequences.
Whole-cell lysates were
prepared from 105 mononuclear cells isolated by
Ficoll-Hypaque gradient centrifugation followed by sonication and
boiling in autoclave-sterilized distilled water and incubation in the
presence of proteinase K (24). Samples were boiled to
inactivate the protease and were then subjected to 30 cycles of PCR
amplification (1 min at 94°C, 1 min at 55°C, and 1.5 min at 72°C
per cycle), followed by a final incubation for 10 min at 72°C in the
buffer and the concentrations of MgCl2 and deoxynucleoside
triphosphates described previously (24). Final reaction
volumes of 80 µl contained 40 pmol of each of the appropriate primers
(see below). Southern analysis following amplification by PCR was
necessary in most cases to detect HTLV sequences. As described
previously, the 3' digoxigenin-tailed probes listed below were used for
hybridization (24, 40). Detection of bound probe entailed
use of Fab' fragments of antibodies to digoxigenin conjugated with
alkaline phosphatase and the alkaline phosphatase substrates
4-nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP). The reagents for tailing and detection of bound probes were
obtained from Boehringer Mannheim (Indianapolis, Ind.).
The primers and probes used in this study were synthesized in the
Oligonucleotide Synthesis and Sequencing Facility at the
New York
University School of Medicine. The sequences and genome
locations of
the HTLV
gag-1 and
env-1 primers and probes were
described by Hall et al. (
9), and the
tax-1 and
-2 primers
SK43 and SK44 and probe SK45 were described by
Kwok et al. (
16).
The HTLV-1-infected cell line C91PL
(
28) was used as the positive
control, and PBMC lysates from
tax sequence-negative volunteers
served as negative controls
in these
assays.
The primers and probe used to detect human DNA sequences in PBMCs from
tax sequence-positive rabbits were designed to amplify
and
identify a 260-bp portion of the coding sequence for human
CD24
(
13). This region encodes a human
Alu sequence
not found
among rabbit genomic sequences (
4,
13). The primer
and probe
sequences used consisted of 5'-CCACGACTAATTTCAAAATGCT-3'
(sense
primer), 5'-AAGCCTGTAATCCCAGCACTTTGGG-3'
(antisense primer), and
5'-GTGCGATCTCGATCATGTACCATTTG-3'
probe. PCR and Southern analyses
were performed as described
before with lysates of PBMCs (
24).
Positive and negative
controls for the assays for detection of
human
Alu sequences
consisted of PBMC lysates from three human
blood donors and two rabbits
which had never been injected with
human cells,
respectively.
Sequence analysis.
The tax sequences amplified
from the donor cells used for inoculation and from PBMCs obtained from
five rabbits injected with tax-only-positive human cells
were subjected to oligonucleotide sequence analysis, as described
previously (39).
The sequences detected in the samples were compared with those
published for HTLV-1 and -2 (
29,
30). For the 87-bp
tax proviral DNA sequence being analyzed, HTLV-1 and -2 differ by
16
bp.
Detection of HTLV-1 tax mRNA in rabbit PBMCs.
Reverse transcription-PCR and Southern analyses were performed with
PBMCs obtained from all nine rabbits 5 months after injection as
described previously (25). Briefly, total cellular RNA was isolated from ~105 PBMCs and was treated with DNase I,
followed by reverse transcription with Moloney murine leukemia virus
reverse transcriptase (GIBCO-BRL, Gaithersburg, Md.) in the presence of
50 pmol of HTLV-1 and -2 tax primer SK43. PCR and Southern
analyses were subsequently carried out with tax primer SK44
and digoxigenin-tailed tax probe SK45 as described above. Positive and
negative controls for these assays consisted of cells of the
HTLV-1-infected cell line C91PL (28) and lysates of PBMCs
from HTLV tax sequence-negative volunteers, respectively.
Detection of HTLV-1 and -2 antibodies.
Plasma specimens from
all nine rabbits were tested for antibodies to the HTLV-1 and -2 structural proteins gag and env with the HTLV
Blot 2.3 kit obtained from Cellular Products (Buffalo, N.Y.), but with
goat anti-rabbit immunoglobulin G (heavy and light chains) conjugated
with alkaline phosphatase (Pierce Chemical Co., Rockford, Ill.) as the
secondary antibody and the alkaline phosphatase substrates NBT and BCIP
as described before (40).
Detection of p40tax antibodies by western
blot analysis.
Since the p40tax antigen is
not commerically available, it was prepared by cloning the proviral DNA
sequences that encode the full-length p40tax-I
open reading frame from the prototypic HTLV-1-infected cell line C91PL
(28) into the glutathione S-transferase fusion
protein expression vector pGEX-2T essentially as described before
(25). Western blot assays were carried out with
thrombin-cleaved p40tax antigens, and plasma
specimens were diluted 1:10 for testing. Blots were developed by using
secondary antibodies (goat-anti rabbit immunoglobulin G; heavy and
light chains conjugated with alkaline phosphatase) (Pierce Chemical
Co.) and the substrates NBT and BCIP.
 |
RESULTS |
All rabbits were negative for HTLV sequences and antibodies prior
to injection of human cells.
Rabbits A and B failed to convert to HTLV sequence and antibody
positivity during the first 3 months after injection with HTLV-1-infected C91PL cells. Therefore, these animals were reinjected with C91PL cells at 3 months, and both animals then converted to being
both HTLV sequence and antibody positivity within 1 month after the
second injections (Tables 1 to
3).
Although PBMCs from both rabbits (A and B) were shown to be positive
for tax mRNA (Table 3), neither animal developed antibodies
to p40tax during the 12 months of observation.
tax sequences were detected in rabbits H and I 3 months
after the first injection with PBMCs from MF patients and/or healthy blood donors (Tables 1 and 2). tax-specific sequences were
not detected in rabbits C, D, E, F, and G until 4 months after
injection of tax-only-positive human cells. A representative
Southern blot of the tax sequences detected in rabbit PBMCs
is shown in Fig. 1.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 1.
Southern blot of 159-bp HTLV-1 tax proviral
DNA sequences amplified by PCR from whole-cell lysates of PBMCs from
rabbits. The tax probe, SK45, used for hybridization was
tailed at the 3' end with digoxigenin, and bound probe was detected by
using Fab' fragments of antibodies to digoxigenin conjugated with
alkaline phosphatase and the alkaline phosphatase substrates NBT and
BCIP. Lanes: 1, HTLV-1-infected cell line C91PL; 2 and 3, plasma from
rabbits A and B, respectively, injected with C91PL cells; 4 to 10, plasma from rabbits C to I, respectively, injected with
tax-only sequence-positive human PBMCs. The arrowhead
indicates the 159-bp tax proviral DNA amplification
product.
|
|
Although tax mRNA was demonstrated in PBMC lysates from all
rabbits except rabbit E (Table 3), none of the rabbits (rabbits C to I)
injected one to seven times with tax-only-positive PBMCs from MF patients and/or healthy blood donors developed antibodies to
p40tax (Table 3). It is noteworthy that this
also pertained to rabbits A and B, which had been inoculated with C91PL
cells that contained the whole virus.
As expected, rabbits A and B became positive for sequences and
antibodies to HTLV-1 structural proteins gag and
env (Tables 2 and 3).
Sequence analyses demonstrated that the same HTLV-1 tax
proviral sequences detected in cells used for injection were present in
PBMCs obtained from rabbits (Fig. 2).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Representative HTLV-1 (HTLV-I) tax sequence detected in
PBMC lysates from five rabbits injected with tax
sequence-only PBMCs from patients with MF or
tax-only-positive blood donors. The tax sequences
for prototypic HTLV-1 and -2 (HTLV-II) are those published by Seiki et
al. (29), and Shimotohno et al. (30),
respectively. Dashed lines indicate sequence identity with the
prototypic HTLV-1 sequence.
|
|
Human CD24-encoded Alu sequences were not detected in PBMCs
from any of the nine tax sequence-positive rabbits tested 6 months after they were first injected with HTLV-1-infected cells
(rabbits A and B) or PBMCs from tax-only-positive donors
(rabbits C to I). Thus, it is unlikely that any human cells survived
and proliferated in the rabbits.
 |
DISCUSSION |
It is well established, that transmission of HTLV-1 infection may
occur by transfusion of cellular blood products obtained from
HTLV-1-positive donors. Because carriers of the virus usually have
antibodies to it, testing for such antibodies, which has been in place
in the United States since 1988 (2), seemed to preclude
infection by this route. However, the existence of seronegative virus
carriers among inhabitants of areas where the virus is endemic has been
recognized. In a study conducted in Japan, it was believed to be
responsible for seroconversion in 3 of 600 blood recipients (20). Moreover, healthy carriers of HTLV-1 as well as
patients with HTLV-1-associated diseases may lose some proviral
sequences while they retain others. In such instances, it is not
unusual for the tax sequence to be retained (12).
Because of the low prevalence of HTLV infection in the United States,
this issue has received little attention. However, patients with MF, as
well as some of their healthy relatives, have deleted HTLV-1 sequences. These individuals commonly retain HTLV-1 tax, while they
test serologically negative for antibodies to the structural proteins of the virus by methods in current use (24, 40). The
possible significance of this observation may have been underscored by observations of a 7-year-old patient with MF whose skin and blood lymphocytes harbored only tax and pol sequences
but who was found to be seronegative for antibodies to HTLV-1. The
patient's healthy mother was serologically positive and a proven
carrier of the complete virus (37). Thus, there is no doubt
that seronegative carriers of viruses from which some proviral
sequences are deleted exist and that this state may be associated with disease.
Recognition that a fairly high percentage of healthy HTLV
antibody-negative U.S. blood donors may also carry deleted HTLV-1 sequences and that it is the tax sequence and its gene
product, p40tax, which are most often retained
(36, 39) should raise concern. It has been established that
p40tax is the transcriptional transactivator of
the long terminal repeat of HTLV-1. In addition, it is instrumental in
the upregulation of innumerable cellular growth factors, cytokines, and
oncogenes (for reviews, see references 1, 6, 31, and
35). Whether HTLV-1 tax can be
transmitted by tax-only-containing cells is an important
question which needed to be addressed. The protocol used to transfer
human tax-only-positive PBMCs to rabbits was the same as the
one used by others to transfer human cells containing the complete
virus to this animal species (3, 17). It is assumed that the
injected virus-containing cells are taken up by rabbit phagocytes and
that they or their progeny are capable of proliferating with the viral
genome. The same theory would be applicable to the transfer of the
tax-only state to rabbits by cells that harbor only the
tax sequence. This seems to have occurred in the experiments
reported here. It should be mentioned that since our studies were
completed, a report by Koya et al. (15) showed that rats
inoculated with allogeneic HTLV-1 tax-containing FPMI cells
retained detectable HTLV-1 tax sequences for more than a
year, while no antibodies to the structural proteins of the virus developed.
The mechanism whereby the tax-only state is maintained in
the absence of replicating virus has not yet been fully explained even
in individuals who were initially infected with the whole virus.
However, because of its strong transactivating function, as well as the
observation that transformed cells do not necessarily contain viral
sequences, and the fact that HTLV tax is usually lost in
preparations designed to isolate high-molecular-weight DNA
(23), it is likely that the tax sequence is
episomal. Indeed, since this paper was first submitted, the authors
have obtained data to support this possibility (41).
Episomal tax may replicate autonomously under the same
controls as chromosomal DNA, i.e., once per cell cycle. This has been
demonstrated for other episomal viral sequences, such as those of
latent Epstein-Barr virus (34; for a review, see
reference 8). In individuals who harbor the complete
virus, the increase in the number of positive cells over time has been
attributed to clonal expansion of HTLV-bearing cells rather than
independent replication of the virus (33). This is believed
to account not only for the long latent period before HTLV-associated
diseases become manifest but also for the remarkable genomic stability
of this virus.
Another question raised by the present observations was whether the
tax-only sequence positivity of injected rabbits was due to
expansion of tax-only-positive rabbit cells or whether
xenotransplantation, i.e., proliferation of tax-positive
human cells, had occurred. Although the latter possibility was
considered remote, tax-harboring cells have a proliferation
advantage (33), and on the basis of studies reviewed in
detail elsewhere (32, 33), it could not be entirely
excluded. However, a search for human sequences in lysates prepared
from tax-only-positive rabbit PBMCs yielded negative
results, thus permitting the conclusion that rabbit cells which had
taken up HTLV-1 tax had proliferated to the level at which
the sequence could be detected. That none of the animals, even those
injected with C91PL cells, generated antibodies to p40tax during the period of observation (12 months) is not surprising since antibodies to
p40tax are late in developing, even in humans,
following primary infection with HTLV-1 (18, 20). Be that as
it may, the studies reported here have provided clear evidence that
HTLV-1 tax can be transmitted by cells which do not carry
intact virus or sequences that encode the structural proteins of
replication-competent HTLV-1. Since the transforming and
transactivating properties of p40tax have been
abundantly demonstrated in vivo as well as in vitro, these observations
warrant consideration in the context of transfusion medicine.
 |
ACKNOWLEDGMENTS |
These studies were supported in part by a grant from the National
Blood Foundation and by the Mendik Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: New York
University School of Medicine, Department of Medicine, TH445, 550 First
Ave., New York, NY 10016. Phone: (212) 263-5634. Fax: (212) 263-8230.
 |
REFERENCES |
| 1.
|
Buckle, G. J.,
D. A. Hafler, and P. Höllsberg.
1996.
HTLV-I-induced T-cell activation.
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
13(Suppl. 1):S107-S113.
|
| 2.
|
Centers for Disease Control and Prevention.
1988.
Licensure of screening tests for antibody to human T lymphotropic virus type I.
Morbid. Mortal. Weekly Rep.
37:736-740[Medline] and 745-747.
|
| 3.
|
Cockerell, G. L.,
M. Lairmore,
D. Barun,
J. Rovnak,
T. M. Hartley, and I. Miyoshi.
1990.
Persistent infection of rabbits with HTLV-I: patterns of anti-viral antibody reactivity and detection of virus by gene amplification.
Int. J. Cancer
45:127-130[Medline].
|
| 4.
|
Gabriel, A.
1995.
Transposons in the human genome, p. 924-928.
In
R. A. Mayers (ed.), Molecular biology and biotechnology. KH Publishers, Inc., New York, N.Y.
|
| 5.
|
Gessain, A.,
F. Barin,
J. C. Vernant,
O. Gout,
L. Maurs,
A. Calenda, and G. de Thé.
1985.
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.
Lancet
ii:407-410.
|
| 6.
|
Gitlin, S. D.,
J. Dittmer,
R. L. Reid, and J. N. Brady.
1993.
The molecular biology of human T-cell leukemia virus, p. 159-192.
In
B. R. Cullen (ed.), Human retroviruses. IRLPress/Oxford University Press, Oxford, United Kingdom.
|
| 7.
|
Green, J. E.,
S. H. Hinrichs,
J. Vogel, and G. Jay.
1989.
Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice.
Nature
341:72-74[CrossRef][Medline].
|
| 8.
|
Haase, S. B., and M. P. Calos.
1991.
Replication control of automomously replicating human sequences.
Nucleic Acids Res.
19:5053-5058[Abstract/Free Full Text].
|
| 9.
|
Hall, W. W.,
C. R. Liu,
O. Schneewind,
H. Takahashi,
M. H. Kaplan,
G. Roupe, and A. Vahlne.
1991.
Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides.
Science
253:317-320[Abstract/Free Full Text].
|
| 10.
|
Iwakura, Y.,
S. Saijo,
Y. Kioka,
J. Nakayama-Yamada,
K. Itagaki,
M. Tosu,
M. Asano,
Y. Kanai, and K. Kakimoto.
1995.
Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
J. Immunol.
155:1588-1598[Abstract].
|
| 11.
|
Kamihira, S.,
K. Toriya,
T. Amagasaki,
S. Momita,
S. Ikeda,
Y. Yamdad,
M. Tomonaga,
M. Ichimaru,
K. Kinoshita, and T. Sawada.
1989.
Antibodies against p40 tax gene product of human T-lymphotropic virus type-I (HTLV-I) under various conditions of HTLV-I infection.
Jpn. J. Cancer Res.
80:1066-1071[Medline].
|
| 12.
|
Kashiwagi, S.,
W. Kajiyama,
J. Hayashi,
A. Noguchi,
K. Nakashima,
H. Nomura,
H. Ikematsu,
T. Sawada,
S. Kida, and A. Koide.
1990.
Antibody to p40 tax protein of human T cell leukemia virus I and infectivity.
J. Infect. Dis.
161:426-429[Medline].
|
| 13.
|
Kay, R.,
P. M. Rosten, and R. K. Humphries.
1991.
CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor.
J. Immunol.
147:1412-1416[Abstract].
|
| 14.
|
Khan, Z. M.,
M. Sebenik, and D. Zucker-Franklin.
1996.
Localization of HTLV-I tax proviral sequences in skin biopsies of patients with mycosis fungoides by in situ polymerase chain reaction.
J. Invest. Dermatol.
106:667-672[CrossRef][Medline].
|
| 15.
|
Koya, Y.,
T. Ohashi,
H. Kato,
S. Hanabuchi,
T. Tsukahara,
F. Takemura,
K. Etoh,
M. Matsuoka,
M. Fujii, and M. Kannagi.
1999.
Establishment of seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.
J. Virol.
73:6436-6443[Abstract/Free Full Text].
|
| 16.
|
Kwok, S.,
D. Kellogg,
G. Ehrlich,
B. Poiesz,
S. Bhagavati, and J. J. Sninsky.
1988.
Characterization of a sequence of the human T cell leukemia virus type-I from a patient with chronic progressive myelopathy.
J. Infect. Dis.
158:1193-1197[Medline].
|
| 17.
|
Lairmore, M. D.,
B. Roberts,
D. Frank,
J. Rovnak,
M. G. Weiser, and G. L. Cockerell.
1992.
Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease.
Int. J. Cancer
50:124-130[Medline].
|
| 18.
|
Manns, A.,
E. L. Murphy,
R. Wilks,
G. Haynes,
J. P. Figueroa,
B. Hanchard,
M. Barnett,
J. Drummond,
D. Waters,
M. Cerney,
J. R. Seals,
S. S. Alexander,
H. Lee, and W. A. Blattner.
1991.
Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
Blood
77:896-905[Abstract/Free Full Text].
|
| 19.
|
Marriott, S. J.,
P. F. Lindholm,
R. L. Reid, and J. N. Brady.
1991.
Soluble HTLV-I tax-1 protein stimulates proliferation of human peripheral blood lymphocytes.
New Biologist
3:678-686[Medline].
|
| 20.
|
Okochi, K., and H. Sato.
1985.
Transmission of ATLV (HTLV-I) through blood transfusion, p. 129-135.
In
M. Miwa, T. Sugimura, and R. A. Weiss (ed.), Retroviruses in human lymphoma/leukemia. Japan Scientific Society Press, Tokyo, Japan.
|
| 21.
|
Okochi, K.,
H. Sato, and Y. A. Hinuma.
1984.
A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipients.
Vox Sang.
46:245-253[Medline].
|
| 22.
|
Osame, M.,
K. Usuku,
S. Izumo,
N. Ijichi,
H. Amitani,
A. Igata,
M. Matsumoto, and M. Tara.
1986.
HTLV-I associated myelopathy: a new clinical entity.
Lancet
i:1031-1032.
|
| 23.
|
Pancake, B. A., and D. Zucker-Franklin.
1996.
The difficulty of detecting HTLV-proviral sequences in patients with mycosis fungoides.
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
13:314-319[Medline].
|
| 24.
|
Pancake, B. A.,
D. Zucker-Franklin, and E. E. Coutavas.
1995.
The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotrophic virus-associated disease. A study of 50 patients.
J. Clin. Invest.
95:547-554.
|
| 25.
|
Pancake, B. A.,
E. H. Wassef, and D. Zucker-Franklin.
1996.
Demonstration of anti-bodies to HTLV-I tax in patients with the cutaneous T cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus.
Blood
88:3004-3009[Abstract/Free Full Text].
|
| 26.
|
Peebles, R. S.,
C. R. Maliszewski,
T. A. Sato,
J. Hanley-Hyde,
I. G. Maroulakou,
R. Hunziker,
J. P. Schneck, and J. E. Green.
1995.
Abnormal B cell function in HTLV-I-tax transgenic mice.
Oncogene
10:1045-1051[Medline].
|
| 27.
|
Poiesz, B. J.,
F. W. Ruscetti,
A. F. Gazdar,
P. A. Bunn,
J. D. Minna, and R. C. Gallo.
1980.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma.
Proc. Natl. Acad. Sci. USA
77:7415-7419[Abstract/Free Full Text].
|
| 28.
|
Popovic, M.,
P. S. Sarin,
M. Robert-Guroff,
V. S. Kalyanaraman,
D. Mann,
J. Minowada, and R. C. Gallo.
1983.
Isolation and transmission of human retrovirus (human T-cell leukemia virus).
Science
219:856-859[Abstract/Free Full Text].
|
| 29.
|
Seiki, M.,
S. Hattori,
Y. Hirayama, and M. Yoshida.
1983.
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.
Proc. Natl. Acad. Sci. USA
80:3618-3622[Abstract/Free Full Text].
|
| 30.
|
Shimotohno, K.,
Y. Takahashi,
N. Shimizu,
T. Gojobori,
D. W. Golde,
I. S. Y. Chen,
M. Miwa, and T. Sugimura.
1985.
Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.
Proc. Natl. Acad. Sci. USA
82:3101-3105[Abstract/Free Full Text].
|
| 31.
|
Sodroski, J.
1992.
The human T-cell leukemia virus (HTLV) transactivator (Tax) protein.
Biochim. Biophys. Acta
1114:19-29[Medline].
|
| 32.
|
Starzl, T. E., and R. M. Zinkernagel.
1998.
Antigen localization and migration in immunity and tolerance.
N. Engl. J. Med.
339:1905-1913[Free Full Text].
|
| 33.
|
Wattel, E.,
J. P. Vartanian,
C. Pannetier, and S. Wain-Hobson.
1995.
Clonal expansion of human T-cell leukemia virus type 1-infected cells in asymptomatic and symptomatic carriers without malignancy.
J. Virol.
69:2863-2868[Abstract].
|
| 34.
|
Yates, J. L., and N. Guan.
1991.
Epstein-Barr virus-derived plasmids replicate once per cell cycle and are not amplified after entry into cells.
J. Virol.
65:483-488[Abstract/Free Full Text].
|
| 35.
|
Yoshida, M.
1994.
HTLVs, p. 929-941.
In
G. Stamatoyannopoulos, A. Nienhuis, P. W. Majeris, and H. Varmus (ed.), The molecular basis of blood diseases. The W. B. Saunders Co., Philadelphia, Pa.
|
| 36.
|
Zucker-Franklin, D., and J. G. Gorman.
1997.
HTLV-I provirus in seronegative healthy blood donors.
Lancet
349:999[Medline].
|
| 37.
|
Zucker-Franklin, D.,
M. Klein Kosann,
B. A. Pancake,
D. L. Ramsay, and N. A. Soter.
1999.
Hypopigmented mycosis fungoides associated with human T cell lymphotropic virus type I tax in a pediatric patient.
Pediatrics
103:1039-1045[Free Full Text].
|
| 38.
|
Zucker-Franklin, D.,
J. W. Melton, and F. Quagliata.
1974.
Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes.
Proc. Natl. Acad. Sci. USA
71:1877-1881[Abstract/Free Full Text].
|
| 39.
|
Zucker-Franklin, D., and B. A. Pancake.
1998.
Human T-cell lymphotropic virus type 1 Tax among American blood donors.
Clin. Diagn. Lab. Immunol.
5:831-835[Abstract/Free Full Text].
|
| 40.
|
Zucker-Franklin, D.,
B. A. Pancake,
M. Marmor, and P. Legler.
1997.
Reexamination of human T cell lymphotropic virus (HTLV-I/II) prevalence.
Proc. Natl. Acad. Sci. USA
94:6403-6407[Abstract/Free Full Text].
|
| 41.
|
Zucker-Franklin, D.,
B. A. Pancake, and V. Najfeld.
1999.
Localization of HTLV-I tax in the nuclei of mononuclear leukocytes of healthy HTLV-I/II seronegative individuals.
Blood
94:440a.
|
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 274-278, Vol. 7, No. 2
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.